The Centers for Medicare & Medicaid Services recently issued a guidance warning about the dangers of opioid-induced respiratory depression (“OIRD”) and required the following actions be taken: Timely ...
This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory depression, which is the shallow and slow ...
Nearly 75 percent of hospitalized patients receiving opioids for pain management are not monitored according to hospital guidelines. A study led by University at Buffalo nursing researcher Carla ...
Respiratory depression has been associated with the use of opioid analgesics. However, a recent study by researchers at Wesley Medical Center in Wichita, Kan., suggests exhaled CO2 monitoring of ...
MURRAY — Parker Stewart was a 21-year-old newlywed in 2016 when he died in his sleep three days after a routine tonsillectomy. He had been prescribed an opioid to help manage his post-operation pain ...
Is there a safe opioid? Scientists discovered DFNZ, a high-potency nitazene that relieves pain without the risk of overdose ...
RED BANK, NJ / ACCESS Newswire / August 20, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic ...
Naloxone, the opioid overdose antidote, is a powerful tool in the overdose crisis, allowing friends, loved ones and even bystanders a way to put a fatal overdose in reverse and bring back breathing.
A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant ...
Brixadi (buprenorphine) is a brand-name injection that’s prescribed for opioid use disorder. As with other drugs, Brixadi can cause side effects, such as injection site reactions and respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results